Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases

American Journal of Hematology

Volumn 53, Issue 4, 1996, Pages 239-241

  Levy V ^a,b   Bourgarit, A ^a   Delmer, A ^a   Legrand, O ^a   Baudard, M ^a   Rio, B ^a   Zittoun, R ^a  

^a HÔTEL DIEU   (France)

^b Service d'Hematologie   (France)

Author keywords

agnogenic myeloid metaplasia; danazol

Indexed keywords

ALPHA INTERFERON; CYTARABINE; DANAZOL; HYDROXYUREA; PREDNISONE;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; MYELOID METAPLASIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANEMIA; COMBINED MODALITY THERAPY; DANAZOL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOID METAPLASIA; SPLENOMEGALY;

EID: 0029906904     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199612)53:4<239::AID-AJH5>3.0.CO;2-Z     Document Type: Article

References (12)

1. Dalla KP, Zeigler ZR, Shadduck RK: α-interferon in myelofibrosis: A case report. Br J Haematol 86:654-656, 1994.
2. Tefferi A, Silverstein MM, Noël P: Agnogenic myeloid metaplasia. Semin Oncol 22:327-333, 1995.
3. Ahn YS, Rocha R, Mylvaganam R, Garcia R: Long-term danazol therapy in autoimmune thrombocytopenia: Unmaintained remission and age dependant response in women. Ann Intern Med 111:723- 728, 1989.
4. Avilés A, Rubio ME, Gomez J, Medina ML, Gonzalez-Llaven J: Randomized study of danazol vs. placebo in myelodysplastic syndromes. Arch Invest Med (Mex) 20:183-188, 1989.
5. Catalano L, Selleri C, Montuori N, Fratellanza G, Notaro R, Fontana R, Formisano S, Rotoli B: Danazol for myelodysplastic syndromes. Br J Haematol 85:230-238, 1993.
6. Wattel E, Cambier N, Caulier M, Sautière D, Bauters F, Fenaux P: Androgen therapy in myelodysplastic syndromes with thrombocytopenia: A report on 20 cases. Br J Haematol 87:205-208, 1994.
7. Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall CM, So AG: Danazol for the treatment of idiopathic thrombocytopenia purpura. N Engl J Med 40:1396-1399, 1983.
8. Ahn YS, Harrington WJ, Mylvaganam R, Ayub J, Pall LM: Danazol therapy for autoimmune hemolytic anaemia. Ann Intern Med 102:298- 301, 1985.
9. Stadtmauer EA, Cassileth EA, Edelstein M, Abraham J, Schreiber AD, Nowel PC, Cines DB: Danazol treatment of myelodysplastic syndromes. Br J Haematol 77:502-508, 1991.
10. Schreiber AD, Chien P, Tomaski A, Cines DB: Effect of danazol in immune thrombocytopenia purpura. N Engl J Med 316:503-508, 1987.
11. Chabannon C, Pegourie B, Sotto JJ, Hollard D: Clinical and hematological improvement in a patient receiving danazol therapy for myelofibrosis with myeloid metaplasia. Nouv Rev Fr Hematol 32:165-166, 1990.
12. Zittoun R, Bernadou A, Blanc CM, Bilski-Pasquier G, Bousser J: Méténolone dans le traitement des insuffisances médullaires. Presse Med 76:445-448, 1968.